378 related articles for article (PubMed ID: 17093970)
1. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles.
Mounier R; Cavalié H; Lac G; Clottes E
Pflugers Arch; 2007 Jan; 453(4):497-507. PubMed ID: 17093970
[TBL] [Abstract][Full Text] [Related]
2. Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol.
Kitaura T; Tsunekawa N; Hatta H
J Appl Physiol (1985); 2001 Jul; 91(1):85-90. PubMed ID: 11408417
[TBL] [Abstract][Full Text] [Related]
3. Effects of the beta2-agonist clenbuterol on beta1- and beta2-adrenoceptor mRNA expressions of rat skeletal and left ventricle muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Pharmacol Sci; 2008 Aug; 107(4):393-400. PubMed ID: 18678986
[TBL] [Abstract][Full Text] [Related]
4. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol.
Awede BL; Thissen JP; Lebacq J
Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E31-7. PubMed ID: 11739080
[TBL] [Abstract][Full Text] [Related]
5. Endurance training adaptations modulate the redox-force relationship of rat isolated slow-twitch skeletal muscles.
Plant DR; Gregorevic P; Warmington SA; Williams DA; Lynch GS
Clin Exp Pharmacol Physiol; 2003; 30(1-2):77-81. PubMed ID: 12542458
[TBL] [Abstract][Full Text] [Related]
6. Interaction of exercise training and clenbuterol on GLUT-4 protein in muscle of obese Zucker rats.
Kuo CH; Ding Z; Ivy JL
Am J Physiol; 1996 Nov; 271(5 Pt 1):E847-54. PubMed ID: 8944671
[TBL] [Abstract][Full Text] [Related]
7. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat.
Rajab P; Fox J; Riaz S; Tomlinson D; Ball D; Greenhaff PL
Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1076-81. PubMed ID: 10956268
[TBL] [Abstract][Full Text] [Related]
8. Effects of unweighting and clenbuterol on myosin light and heavy chains in fast and slow muscles of rat.
Stevens L; Firinga C; Gohlsch B; Bastide B; Mounier Y; Pette D
Am J Physiol Cell Physiol; 2000 Nov; 279(5):C1558-63. PubMed ID: 11029303
[TBL] [Abstract][Full Text] [Related]
9. Effects of chronic administration of clenbuterol on contractile properties and calcium homeostasis in rat extensor digitorum longus muscle.
Sirvent P; Douillard A; Galbes O; Ramonatxo C; Py G; Candau R; Lacampagne A
PLoS One; 2014; 9(6):e100281. PubMed ID: 24971566
[TBL] [Abstract][Full Text] [Related]
10. Adaptations in rat skeletal muscle following long-term resistance exercise training.
Duncan ND; Williams DA; Lynch GS
Eur J Appl Physiol Occup Physiol; 1998 Mar; 77(4):372-8. PubMed ID: 9562367
[TBL] [Abstract][Full Text] [Related]
11. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice.
Hayes A; Williams DA
Clin Exp Pharmacol Physiol; 1994 Oct; 21(10):757-65. PubMed ID: 7867226
[TBL] [Abstract][Full Text] [Related]
12. The effects of intraperitoneal clenbuterol injection on protein degradation and myostatin expression differ between the sartorius and pectoral muscles of neonatal chicks.
Ijiri D; Ishitani K; Shimamoto S; Ishimaru Y; Ohtsuka A
Gen Comp Endocrinol; 2014 Sep; 206():111-7. PubMed ID: 25117456
[TBL] [Abstract][Full Text] [Related]
13. Chronic clenbuterol treatment compromises force production without directly altering skeletal muscle contractile machinery.
Py G; Ramonatxo C; Sirvent P; Sanchez AM; Philippe AG; Douillard A; Galbès O; Lionne C; Bonnieu A; Chopard A; Cazorla O; Lacampagne A; Candau RB
J Physiol; 2015 Apr; 593(8):2071-84. PubMed ID: 25656230
[TBL] [Abstract][Full Text] [Related]
14. Time course in calpain activity and autolysis in slow and fast skeletal muscle during clenbuterol treatment.
Douillard A; Galbes O; Rossano B; Vernus B; Bonnieu A; Candau R; Py G
Can J Physiol Pharmacol; 2011 Feb; 89(2):117-25. PubMed ID: 21326343
[TBL] [Abstract][Full Text] [Related]
15. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition.
Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S
PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620
[TBL] [Abstract][Full Text] [Related]
16. Adaptive effects of the beta2-agonist clenbuterol on expression of beta2-adrenoceptor mRNA in rat fast-twitch fiber-rich muscles.
Sato S; Nomura S; Kawano F; Tanihata J; Tachiyashiki K; Imaizumi K
J Physiol Sci; 2010 Mar; 60(2):119-27. PubMed ID: 20033361
[TBL] [Abstract][Full Text] [Related]
17. Effect of the beta 2-adrenergic agonist clenbuterol on the growth of fast- and slow-twitch skeletal muscle of the dystrophic (C57BL6J dy2J/dy2J) mouse.
Agbenyega ET; Morton RH; Hatton PA; Wareham AC
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1995 Jul; 111(3):397-403. PubMed ID: 8564781
[TBL] [Abstract][Full Text] [Related]
18. Effects of beta 2-agonist administration and exercise on contractile activation of skeletal muscle fibers.
Lynch GS; Hayes A; Campbell SP; Williams DA
J Appl Physiol (1985); 1996 Oct; 81(4):1610-8. PubMed ID: 8904577
[TBL] [Abstract][Full Text] [Related]
19. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats.
Chen KD; Alway SE
J Appl Physiol (1985); 2000 Aug; 89(2):606-12. PubMed ID: 10926644
[TBL] [Abstract][Full Text] [Related]
20. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles.
Bricout VA; Serrurier BD; Bigard AX
Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
